Compass Therapeutics, Inc. (CMPX)

Compass Therapeutics Statistics

Total Valuation

CMPX has a market cap or net worth of $416.88 million. The enterprise value is $266.36 million.

Market Cap	416.88M
Enterprise Value	266.36M

Important Dates

The next estimated earnings date is Thursday, March 20, 2025, before market open.

Earnings Date	Mar 20, 2025
Ex-Dividend Date	n/a

Share Statistics

CMPX has 137.59 million shares outstanding. The number of shares has increased by 8.22% in one year.

Current Share Class	137.59M
Shares Outstanding	137.59M
Shares Change (YoY)	+8.22%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	4.78%
Owned by Institutions (%)	48.54%
Float	89.00M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.56
P/TBV Ratio	2.85
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	313.36
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 31.84, with a Debt / Equity ratio of 0.05.

Current Ratio	31.84
Quick Ratio	30.54
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -32.00% and return on invested capital (ROIC) is -22.55%.

Return on Equity (ROE)	-32.00%
Return on Assets (ROA)	-21.71%
Return on Capital (ROIC)	-22.55%
Revenue Per Employee	$26,563
Profits Per Employee	-$1.49M
Employee Count	32
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +97.93% in the last 52 weeks. The beta is 0.76, so CMPX's price volatility has been lower than the market average.

Beta (5Y)	0.76
52-Week Price Change	+97.93%
50-Day Moving Average	1.69
200-Day Moving Average	1.49
Relative Strength Index (RSI)	79.91
Average Volume (20 Days)	2,213,502

Short Selling Information

The latest short interest is 2.21 million, so 1.61% of the outstanding shares have been sold short.

Short Interest	2.21M
Short Previous Month	2.10M
Short % of Shares Out	1.61%
Short % of Float	2.48%
Short Ratio (days to cover)	5.85

Income Statement

In the last 12 months, CMPX had revenue of $850,000 and -$47.76 million in losses. Loss per share was -$0.35.

Revenue	850,000
Gross Profit	850,000
Operating Income	-55.44M
Pretax Income	-47.24M
Net Income	-47.76M
EBITDA	-54.83M
EBIT	-55.44M
Loss Per Share	-$0.35

Balance Sheet

The company has $135.40 million in cash and $6.88 million in debt, giving a net cash position of $128.53 million or $0.93 per share.

Cash & Cash Equivalents	135.40M
Total Debt	6.88M
Net Cash	128.53M
Net Cash Per Share	$0.93
Equity (Book Value)	138.40M
Book Value Per Share	1.01
Working Capital	136.71M

Cash Flow

In the last 12 months, operating cash flow was -$48.05 million and capital expenditures -$53,000, giving a free cash flow of -$48.10 million.

Operating Cash Flow	-48.05M
Capital Expenditures	-53,000
Free Cash Flow	-48.10M
FCF Per Share	-$0.35

Margins

Gross Margin	100.00%
Operating Margin	-6,522.82%
Pretax Margin	-5,618.47%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CMPX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-8.22%
Shareholder Yield	-8.22%
Earnings Yield	-12.09%
FCF Yield	-12.18%

Analyst Forecast

The average price target for CMPX is $13.75, which is 353.81% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$13.75
Price Target Difference	353.81%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CMPX has an Altman Z-Score of 7.95 and a Piotroski F-Score of 1.

Altman Z-Score	7.95
Piotroski F-Score	1